Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Gynecologic Oncology|February 6, 2019
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancerMegan L Hutchcraft, Blair Smith, Eric M McLaughlin, et al.
Gynecologic Oncology|May 11, 2026
Real-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventyEliya Shachar, Gilat Rotkop, Roni Haas, et al.
American Journal of Obstetrics and Gynecology|August 12, 2019
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasiaMonica Hagan Vetter, Blair Smith, Jason Benedict, et al.
Gynecologic Oncology|July 29, 2015
Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterMargaret I Liang, Adam C ElNaggar, Silpa Nekkanti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2016
Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective CohortFloor J Backes, Adam C ElNaggar, Michael Ryan Farrell, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Gynecologic Oncology|October 8, 2013
Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality careMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Gynecologic Oncology|November 10, 2012
The impact of close surgical margins after radical hysterectomy for early-stage cervical cancerGeorgia A McCann, Susanne K Taege, Christina E Boutsicaris, et al.
Gynecologic Oncology|January 30, 2013
Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage diseaseGeorgia A McCann, Christina E Boutsicaris, Megan M Preston, et al.
Pageof 16